MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
- PMID: 31158804
- DOI: 10.1016/j.msard.2019.05.021
MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
Abstract
MOG-antibody associated demyelinating disease is a new emerging diagnostic entity. Recently, international recommendations for testing of anti-MOG antibodies were published. Herein, we describe a case of anti-MOG antibody-associated demyelinating disease initially diagnosed as typical MS, and, at presentation, not fulfilling the proposed recommendations. This case highlights the expanding spectrum of anti-MOG antibody-associated demyelinating disease, illustrating the distinct and overlapping features of MS and MOG-antibody associated demyelinating disease, providing evidence that on rare occasions these recommendations may prove too restrictive.
Keywords: Anti-MOG antibodies; Anti-MOG antibody testing; MOG antibody-associated demyelination; Multiple sclerosis.
Copyright © 2019 Elsevier B.V. All rights reserved.
Comment in
-
Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS.Mult Scler Relat Disord. 2019 Oct;35:34-35. doi: 10.1016/j.msard.2019.06.037. Epub 2019 Jun 29. Mult Scler Relat Disord. 2019. PMID: 31299419 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
